The purpose of this clinical trial is to evaluate the efficacy and safety of Olistic Next Women, a nutraceutical supplement, in women experiencing beginning of female pattern hair loss (FPHL).This 6-month, double-blind, placebo-controlled, 2:1 randomized clinical trial investigates whether daily supplementation with Olistic Next Women leads to significant improvements in hair parameters compared to placebo. The study also monitors the tolerability and safety of the product throughout the intervention.
Female subjects with female pattern hair loss
45-65 years
Signed informed consent
The study participant is in good general condition for her age and does not currently have any active diseases that, in the opinion of the investigator, justify exclusion from the study.
Known or documented intolerance/allergy to any of the ingredients of the study product
Chronic wounds, erosions, pre-existing infected skin or inflammation in the study area
Suspected non-compliance
Late onset acne